Cart
sales@molnova.com
Mycophenolate mofetil (b)
CAS No. 115007-34-6
Mycophenolate mofetil (b)( —— )
Catalog No. M10529 CAS No. 115007-34-6
Mycophenolate mofetil is the 2-morpholinoethyl ester of mycophenolic acid (MPA), an immunosuppressive agent, inosine monophosphate dehydrogenase (IMPDH) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 65 | In Stock |
|
| 25MG | 29 | In Stock |
|
| 50MG | 41 | In Stock |
|
| 100MG | 59 | In Stock |
|
| 200MG | 90 | In Stock |
|
| 500MG | 153 | In Stock |
|
| 1G | 239 | In Stock |
|
Biological Information
-
Product NameMycophenolate mofetil (b)
-
NoteResearch use only, not for human use.
-
Brief DescriptionMycophenolate mofetil is the 2-morpholinoethyl ester of mycophenolic acid (MPA), an immunosuppressive agent, inosine monophosphate dehydrogenase (IMPDH) inhibitor.
-
DescriptionMycophenolate mofetil is the 2-morpholinoethyl ester of mycophenolic acid (MPA), an immunosuppressive agent, inosine monophosphate dehydrogenase (IMPDH) inhibitor. (In Vitro):The inosine monophosphate dehydrogenase is an important enzyme in the de novo synthesis of guanosine nucleotides in T and B lymphocytes.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetDehydrogenase
-
RecptorIMPDH
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number115007-34-6
-
Formula Weight433.5
-
Molecular FormulaC23H31NO7
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESCC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nakanishi T, et al. Int Immunopharmacol. 2010, 10(1), 91-97.
molnova catalog
related products
-
GSK321
GSK321 is a selective and potent mutant isocitrate dehydrogenase 1 (IDH1) inhibitor that inhibits lipid synthesis and blocks cell proliferation in OPA1-deficient MEFs and prevents cytoplasmic glutamine reductive carboxylation.GSK321 has been used in the study of leukemia.
-
LDH-IN-1
LDH-IN-1 is a novel pyrazole-based inhibitor of human lactate dehydrogenase (LDH) with IC50s of 32 and 27 nM for LDHA and LDHB, respectively.?LDH-IN-1 inhibits the growth of MiaPaCa2 pancreatic cancer and A673 sarcoma cells with IC50s of 2.23 and 1.21 μM).
-
PHGDH-IN-3
PHGDH-IN-3 is an orally active phosphoglycerate dehydrogenase (PHGDH) inhibitor with an IC50 of 2.8 μM against PHGDH, and it can be used in cancer research.
